In the current state of prostate cancer screening, PSA is the most commonly used index (24, 25), Despite this, PCa and BPH were difficult to distinguish at PSA values between 4 and 20 ng/mL in some cases. This evidence concerns the gene KLK3 and posterior cortical atrophy.